27:14

Sidley’s Liekefett On War-and-Peace-Time in Activism

02:01

Financial Success Strategies Highlights

05:44

M&A Sector Review

04:32

The Deal Speaks with EY about their Global Capital Confidence Barometer

03:46

How Corporate Boards Can Best Deal With Activism

08:12

How Corporate Boards Can Meet the Governance Challenge Posed by Activism

03:33

Jeff Marell of Paul Weiss discusses recent appraisal cases

06:06

Steven Williams of Paul Weiss: Companies Must Prep Before An Activist Shows

57:16

How will today’s global environment affect M&A?

03:46

There is No One Size Fits All Model for Value Creation When It Comes to PE

03:34

A Focus on Working Capital Improvement Can Help Drive Strategic Growth

02:57

Deal Making Activity Remains Strong in Healthcare, Despite Uncertainties

03:00

Buyers Need to do a Deep Dive on Due Diligence to Unlock Deal Value in the Current Environment

07:17

How significant a change are we likely to see in the pace of M&A deals after Brexit?

07:31

How Will London’s FinTech Sector Fare Post-Brexit?

05:29

Deals Take Pause After Brexit

05:07

The Impact of Brexit on the Tech Market

04:34

Does Brexit Provide an Opportunity for Tech Investment?

08:43

What kind of challenges can we expect in merger activity now that Britain has triggered its EU exit?

08:28

What makes the UK an attractive hub for fintech?

07:27

How is Brexit expected to impact European companies working within the UK?

59:01

The State of Private Equity: Current Trends and Outlook

59:11

Sector M&A Outlook for 2017

59:23

Pharma Outlook for 2017

56:57

Creating Deal Value Through Performance Improvement & Integration

04:44

Brexit Will Unlock Short-term Opportunities For Activists

05:14

Intralinks Says Number of Deals in Q1 Should Rise 5%

03:31

How Will the Trump Administration Impact Private Equity?

05:27

Divesting Strategies for 2017

04:49

As Activist Investors Turn Their Attention to Asia and Europe, Greater Diversity on Boards is Vital

01:39

AMN Healthcare’s Salka Eyes “Chronic” Shortages In Healthcare Staffing

07:42

There’s more to winning bids than making the highest offer

05:27

Activist Investor Eyes Governance Flaws with Bauer Maker

03:35

Ardian's Fandozzi Eyes Plastics and Chemical Company Deals in 2017

04:37

How Blue Point Finds Good Returns in an Era of Slow Growth and Tougher Competition

07:05

Helping Growth Companies Avoid Young Firms' Common Mistakes

04:47

Why the Trump Plan Could Lead to a Surge in Foreign Investment

03:56

Have All of the Easy Deals Already Been Done?

02:18

EY Capital Confidence Barometer Reveals Most Upbeat Survey Results Ever

05:35

M&A Should Remain Robust in 2017, Says Latham & Watkins

58:13

Title: Middle Market Global Dealmaking Review & Outlook

04:23

U.K. shareholder engagement still limited says TUC

01:21

Trade Union Congress says worker representation needed on U.K. boards

03:47

Trade Union Congress welcomes U.K. government inquiry into corporate governance

06:23

Corporate governance framework means that the U.K. could see more activism in the coming years

04:24

U.S. Activists Have Discovered a Less Aggressive Approach Works Better In Europe

02:32

Activism in Europe is Evolving With The Emergence of Local Players

02:53

Proactivity & communication are key for companies at risk

03:36

A Strategic Public Equity approach to public companies

56:17

Best Practices in Cross Border Dealmaking

05:54

M&A Trends Will Remain Strong , Says McKinsey

08:54

How PE Firms Should Structure Agreements to Protect Against Alleged Fraud in Portfolio Companies

04:30

Intralinks discusses merger integration

01:00:42

Best Practices in Client Communications

57:18

Investment Opportunities to Watch in Biotech

01:02:01

Regulatory Risk Management

54:09

Commercial Real Estate Look Ahead

57:26

Examining Sectors with Disruption

03:06

W. P. Carey on the Competitive U.S. Sale-Leaseback Market

04:59

Merger Talk: Real Estate